These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24184910)

  • 1. Exploitation of auxotrophies and metabolic defects in Toxoplasma as therapeutic approaches.
    Coppens I
    Int J Parasitol; 2014 Feb; 44(2):109-20. PubMed ID: 24184910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biogenesis of and activities at the Toxoplasma gondii parasitophorous vacuole membrane.
    Sinai AP
    Subcell Biochem; 2008; 47():155-64. PubMed ID: 18512349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies.
    Coppens I
    Nat Rev Microbiol; 2013 Dec; 11(12):823-35. PubMed ID: 24162026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoplasma gondii: the model apicomplexan.
    Kim K; Weiss LM
    Int J Parasitol; 2004 Mar; 34(3):423-32. PubMed ID: 15003501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecules targeting the purine salvage pathway in Apicomplexan parasites.
    Ghérardi A; Sarciron ME
    Trends Parasitol; 2007 Aug; 23(8):384-9. PubMed ID: 17574921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine metabolism in Toxoplasma gondii: potential targets for chemotherapy.
    el Kouni MH
    Curr Pharm Des; 2007; 13(6):581-97. PubMed ID: 17346176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A small-molecule approach to studying invasive mechanisms of Toxoplasma gondii.
    Carey KL; Westwood NJ; Mitchison TJ; Ward GE
    Proc Natl Acad Sci U S A; 2004 May; 101(19):7433-8. PubMed ID: 15123807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Toxoplasma gondii parasitophorous vacuole membrane: transactions across the border.
    Martin AM; Liu T; Lynn BC; Sinai AP
    J Eukaryot Microbiol; 2007; 54(1):25-8. PubMed ID: 17300514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Toxoplasma Parasitophorous Vacuole: An Evolving Host-Parasite Frontier.
    Clough B; Frickel EM
    Trends Parasitol; 2017 Jun; 33(6):473-488. PubMed ID: 28330745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxoplasma gondii scavenges mammalian host organelles through the usurpation of host ESCRT-III and Vps4A.
    Romano JD; Mayoral J; Guevara RB; Rivera-Cuevas Y; Carruthers VB; Weiss LM; Coppens I
    J Cell Sci; 2023 Feb; 136(4):. PubMed ID: 36718630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host lipid droplets: An important source of lipids salvaged by the intracellular parasite Toxoplasma gondii.
    Nolan SJ; Romano JD; Coppens I
    PLoS Pathog; 2017 Jun; 13(6):e1006362. PubMed ID: 28570716
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Wang Y; Sangaré LO; Paredes-Santos TC; Saeij JPJ
    Annu Rev Microbiol; 2020 Sep; 74():567-586. PubMed ID: 32680452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyruvate Homeostasis as a Determinant of Parasite Growth and Metabolic Plasticity in Toxoplasma gondii.
    Xia N; Ye S; Liang X; Chen P; Zhou Y; Fang R; Zhao J; Gupta N; Yang S; Yuan J; Shen B
    mBio; 2019 Jun; 10(3):. PubMed ID: 31186321
    [No Abstract]   [Full Text] [Related]  

  • 14. Pleiotropic effect due to targeted depletion of secretory rhoptry protein ROP2 in Toxoplasma gondii.
    Nakaar V; Ngô HM; Aaronson EP; Coppens I; Stedman TT; Joiner KA
    J Cell Sci; 2003 Jun; 116(Pt 11):2311-20. PubMed ID: 12711703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxoplasma gondii sequesters lysosomes from mammalian hosts in the vacuolar space.
    Coppens I; Dunn JD; Romano JD; Pypaert M; Zhang H; Boothroyd JC; Joiner KA
    Cell; 2006 Apr; 125(2):261-74. PubMed ID: 16630815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhoptries are major players in Toxoplasma gondii invasion and host cell interaction.
    Dubremetz JF
    Cell Microbiol; 2007 Apr; 9(4):841-8. PubMed ID: 17346309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Toxoplasma and malaria parasites defy first, then exploit host autophagic and endocytic pathways for growth.
    Coppens I
    Curr Opin Microbiol; 2017 Dec; 40():32-39. PubMed ID: 29102900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting to rhoptry organelles of Toxoplasma gondii involves evolutionarily conserved mechanisms.
    Hoppe HC; Ngô HM; Yang M; Joiner KA
    Nat Cell Biol; 2000 Jul; 2(7):449-56. PubMed ID: 10878811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of two T. gondii CK1 isoforms.
    Donald RG; Zhong T; Meijer L; Liberator PA
    Mol Biochem Parasitol; 2005 May; 141(1):15-27. PubMed ID: 15811523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases.
    Martens S; Parvanova I; Zerrahn J; Griffiths G; Schell G; Reichmann G; Howard JC
    PLoS Pathog; 2005 Nov; 1(3):e24. PubMed ID: 16304607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.